FDA's Current Ability to Regulate Genetic Testing is Problematic, FDLI-AAAS Colloquium Attendees Say

News   Jun 30, 2009

 
FDA's Current Ability to Regulate Genetic Testing is Problematic, FDLI-AAAS Colloquium Attendees Say
 
 
 

RELATED ARTICLES

Autism Risk Higher if Pregnant Mothers Have Infection Requiring Hospitalization

News

Studies have shown that mothers who experience an infection severe enough to require hospitalization during pregnancy are at higher risk of having a child with autism.

READ MORE

£2.2M Collaboration to Fuel Drug Developments for HIV

News

A collaboration between the University of Liverpool and the Johns Hopkins University School of Medicine (JHUSM) has been awarded a further £2.2M ($3M) to develop sophisticated new medicines for HIV.

READ MORE

Human Organ-on-a-Chip Project Launched to Model Influenza Infection

News

The Wyss Institute for Biologically Inspired Engineering have developed a human Organ-on-a-Chip (Organ Chip) microfluidic cell culture technology to develop clinically relevant in vitro models of influenza infection.

READ MORE

 

Comments | 0 ADD COMMENT

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE